Press Releases

03.04.2020

Susan Hockfield Elected to Pfizer’s Board of Directors

03.02.2020

U.S. FDA Accepts Regulatory Submission for Tanezumab, a Potential First-in-Class Treatment for Patients with Chronic Pain Due to Moderate-to-Severe Osteoarthritis

02.27.2020

James Quincey Elected to Pfizer’s Board of Directors

02.27.2020

Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer

02.27.2020

Mylan and Pfizer Finalize Appointments to Viatris Board of Directors

02.27.2020

Mylan and Pfizer Announce Appointment of Viatris Chief Financial Officer

02.27.2020

Mylan and Pfizer Finalize Appointments to Viatris Board of Directors

02.25.2020

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

02.20.2020

Montis Biosciences launched with €8,4 million seed financing and a novel approach to immune-oncology

02.18.2020

European Commission Approves VYNDAQEL®, the First Treatment in the EU for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

02.11.2020

XTANDI® (enzalutamide) Demonstrates Significant Improvement in Overall Survival in Phase 3 PROSPER Trial of Patients with nmCRPC

01.31.2020

Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, RUXIENCE™ (rituximab)